Conference Coverage

Debris left after TAVR varies by device


 

AT CRT 2018

– All transcatheter aortic valve replacement devices generate debris into the bloodstream, including debris larger than 1 mm, but the amount of the debris differs between devices, according to a study based on collections from a cerebral embolic protection system.

“The quantity of the debris measured by different methods and techniques revealed more debris in patients receiving the Evolut R or Lotus TAVR [transcatheter aortic valve replacement] devices than in patients receiving a Sapien 3 or Sapien XT prosthesis,” reported Tobias Schmidt, MD, a cardiologist at Asklepios Klinik St. Georg, Hamburg, Germany.

Dr. Tobias Schmidt

The finding was based on data derived from the SENTINEL IDE and SENTINEL H studies, which were conducted to evaluate whether capture of debris by the Sentinel Cerebral Protection System (CPS) during TAVR procedures reduces risk of stroke and other embolic events. Of the 526 patients participating in these studies, Dr. Schmidt presented histopathological and histomorphological data from 246 patients at CRT 2018 sponsored by the Cardiovascular Research Institute at Washington Hospital Center. The primary results of the SENTINEL studies were presented previously.

Of the 246 patients, 145 (59%) received a Sapien 3 device, 40 (16%) received an Evolut R, 36 (14%) received a Lotus, and 25 (10%) received a Sapien XT. Particle features based on histopathological and histomorphological analyses were compared. A multivariate analysis was conducted to test for interaction with the amount of debris according to patient demographics and procedural characteristics, which differed for the devices evaluated.

Pages

Recommended Reading

Next-day discharge after TAVR shows promise
MDedge Cardiology
How to lower occupational radiation exposure in the cath lab
MDedge Cardiology
Thrombectomy’s success treating strokes prompts rethinking of selection criteria
MDedge Cardiology
Trial shows ‘signals’ in favor of general anesthesia during EVT for stroke
MDedge Cardiology
Revascularization in paraplegics best performed with PCI
MDedge Cardiology
MOMENTUM 3 HeartMate 3 LVAD ‘practice changing’
MDedge Cardiology
VIDEO: Dabigatran effective for myocardial injury after noncardiac surgery
MDedge Cardiology
Radial access PCI best for acute coronary syndrome patients
MDedge Cardiology
CT angiography boosts success in chronic total occlusion revascularization
MDedge Cardiology
VIDEO: PFO closure device 100% effective against future strokes
MDedge Cardiology